title: Achieving optimal delivery of follow-up care for prostate cancer survivors: improving patient outcomes.
abstract: BACKGROUND
  Prostate cancer is the most commonly diagnosed cancer in men in the US, and the second most prevalent cancer in men worldwide. High incidence and survival rates for prostate cancer have resulted in a large and growing population of long-term prostate cancer survivors. Long-term follow-up guidelines have only recently been developed to inform approaches to this phase of care for the prostate cancer population.
  
  
  METHODS
  A PubMed search of English literature through August 2014 was performed. Articles were retrieved and reviewed to confirm their relevance. Patient-reported measures that were used in studies of long-term prostate cancer survivors (ie, at least 2 years posttreatment) were reviewed and included in the review.
  
  
  RESULTS
  A total of 343 abstracts were initially identified from the database search. After abstract review, 105 full-text articles were reviewed of which seven met inclusion criteria. An additional 22 articles were identified from the references of the included articles, and 29 were retained. From the 29 articles, 68 patient-reported outcome measures were identified. The majority (75%) were multi-item scales that had been previously validated in existing literature. We identified four main areas of assessment: 1) physical health; 2) quality of life - general, physical, and psychosocial; 3) health promotion - physical activity, diet, and tobacco cessation; and 4) care quality outcomes.
  
  
  CONCLUSIONS
  There are a number of well-validated measures that assess patient-reported outcomes that document key aspects of long-term follow-up with respect to patient symptoms and quality of life. However, there are fewer patient-reported outcomes related to health promotion and care quality within the prevention, surveillance, and care coordination components of cancer survivorship. Future research should focus on development of additional patient-centered and patient-related outcomes that enlarge the assessment portfolio.
authors.affiliation: Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, Somerset.
authors.forename: Shawna V
authors.initials: SV
authors.lastname: Hudson
authors.affiliation: Rutgers School of Social Work, New Brunswick, NJ.
authors.forename: Denalee M
authors.initials: DM
authors.lastname: O'Malley
authors.affiliation: Cancer Prevention and Control Program, Fox Chase Cancer Center/Temple University Health System, Philadelphia, PA, USA.
authors.forename: Suzanne M
authors.initials: SM
authors.lastname: Miller
keywords: cancer survivorship; follow-up care; patient-reported outcomes; prostate cancer; systematic review
references.citation: Cancer Causes Control. 2013 Jun;24(6):1119-28
references.pmid: 23519639
references.citation: CA Cancer J Clin. 2012 Jul-Aug;62(4):243-74
references.pmid: 22539238
references.citation: Curr Urol Rep. 2010 May;11(3):139-46
references.pmid: 20425619
references.citation: BMJ. 2010 Sep 14;341:c4543
references.pmid: 20843937
references.citation: J Urol. 2010 Apr;183(4):1366-72
references.pmid: 20188381
references.citation: CA Cancer J Clin. 2012 Jul-Aug;62(4):220-41
references.pmid: 22700443
references.citation: Cancer. 2002 Jul 15;95(2):281-6
references.pmid: 12124827
references.citation: Semin Oncol. 2013 Dec;40(6):804-12
references.pmid: 24331199
references.citation: Urology. 2003 Jul;62(1):110-5
references.pmid: 12837433
references.citation: Eur Urol. 2012 Dec;62(6):976-83
references.pmid: 22698574
references.citation: Br J Health Psychol. 2003 Sep;8(Pt 3):271-86
references.pmid: 14606973
references.citation: Urology. 2004 Mar;63(3):532-7; discussion 538
references.pmid: 15028452
references.citation: BJU Int. 2011 Mar;107(6):882-91
references.pmid: 21392207
references.citation: Cancer. 2000 Jan 1;88(1):226-37
references.pmid: 10618627
references.citation: Cancer Nurs. 2013 Mar-Apr;36(2):104-13
references.pmid: 22728952
references.citation: Eur Urol. 2011 Jan;59(1):61-71
references.pmid: 21056534
references.citation: J Cancer Surviv. 2010 Jun;4(2):128-39
references.pmid: 20091248
references.citation: Cancer. 2011 Apr 1;117(7):1429-37
references.pmid: 21425143
references.citation: Urology. 2000 Dec 20;56(6):899-905
references.pmid: 11113727
references.citation: J Oncol Pract. 2014 Mar;10(2):107-12
references.pmid: 24399853
references.citation: N Engl J Med. 2013 Jan 31;368(5):436-45
references.pmid: 23363497
references.citation: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references.pmid: 19474385
references.citation: Qual Life Res. 2006 Dec;15(10):1607-12
references.pmid: 16826441
references.citation: Ann Intern Med. 2012 Jul 17;157(2):120-34
references.pmid: 22801674
references.citation: J Urol. 1992 Nov;148(5):1549-57; discussion 1564
references.pmid: 1279218
references.citation: Med Care. 1998 Jul;36(7):1002-12
references.pmid: 9674618
references.citation: Int J Impot Res. 2005 Jul-Aug;17(4):307-19
references.pmid: 15875061
references.citation: J Cancer Surviv. 2014 Mar;8(1):121-30
references.pmid: 24214413
references.citation: Cancer. 2008 Sep 15;113(6):1471-9
references.pmid: 18666212
references.citation: J Cancer Surviv. 2014 Jun;8(2):190-8
references.pmid: 24317972
references.citation: Ann Intern Med. 2008 Mar 18;148(6):435-48
references.pmid: 18252677
references.citation: Eur Urol. 2008 Oct;54(4):785-93
references.pmid: 18585849
references.citation: Urology. 1995 Jun;45(6):1007-13; discussion 1013-5
references.pmid: 7771002
references.citation: Cancer. 2001 Sep 15;92(6):1451-9
references.pmid: 11745222
references.citation: J Clin Oncol. 2009 Aug 20;27(24):3916-22
references.pmid: 19620493
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1969-76
references.pmid: 17035407
references.citation: J Clin Oncol. 2012 Aug 20;30(24):3020-5
references.pmid: 22802323
references.citation: Geriatr Nurs. 2005 May-Jun;26(3):166-75
references.pmid: 15973345
references.citation: BJU Int. 2011 Sep;108(5):660-4
references.pmid: 21223479
references.citation: Cancer Nurs. 2007 Jul-Aug;30(4):302-8
references.pmid: 17666980
references.citation: J Clin Oncol. 2013 Feb 10;31(5):631-40
references.pmid: 23295805
references.citation: Oncol Nurs Forum. 2013 Nov;40(6):567-73
references.pmid: 24161635
references.citation: Psychooncology. 2009 Dec;18(12):1252-60
references.pmid: 19156675
references.citation: J Natl Cancer Inst. 2009 Jun 16;101(12):888-92
references.pmid: 19509365
references.citation: J Clin Oncol. 2012 Jul 1;30(19):2354-61
references.pmid: 22614994
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: Health Qual Life Outcomes. 2009 Nov 13;7:94
references.pmid: 19912640
references.citation: JAMA. 2009 Sep 16;302(11):1202-9
references.pmid: 19755699
references.citation: J Clin Oncol. 2007 Sep 20;25(27):4171-7
references.pmid: 17635953
references.citation: CA Cancer J Clin. 2014 Jul-Aug;64(4):225-49
references.pmid: 24916760
references.citation: BJU Int. 2007 Sep;100(3):540-3
references.pmid: 17550414
references.citation: J Natl Compr Canc Netw. 2012 Sep;10 (9):1081-7
references.pmid: 22956807
references.citation: Ann Fam Med. 2012 Sep-Oct;10(5):418-27
references.pmid: 22966105
references.citation: Urology. 2003 Dec;62(6):1103-8
references.pmid: 14665364
references.citation: J Cancer Surviv. 2011 Mar;5(1):27-34
references.pmid: 21132395
references.citation: Urology. 2010 Nov;76(5):1245-50
references.pmid: 20350762
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: Transl Behav Med. 2012 Sep;2(3):322-331
references.pmid: 23606921
references.citation: Ann Intern Med. 2011 Dec 6;155(11):762-71
references.pmid: 21984740
references.citation: Psychooncology. 2002 Nov-Dec;11(6):518-23
references.pmid: 12476433
references.citation: Cancer Causes Control. 2007 Apr;18(3):279-85
references.pmid: 17206534
references.citation: Cancer. 2007 Dec 15;110(12):2809-18
references.pmid: 17999405
references.citation: J Clin Oncol. 2004 Oct 15;22(20):4193-201
references.pmid: 15483030
references.citation: BJU Int. 2014 Dec;114(6b):E74-81
references.pmid: 24588845
references.citation: Clin J Oncol Nurs. 2012 Feb;16(1):65-72
references.pmid: 22297009
references.citation: J Natl Cancer Inst. 2009 Jun 16;101(12):878-87
references.pmid: 19509351
references.citation: N Engl J Med. 2011 May 5;364(18):1708-17
references.pmid: 21542742
references.citation: Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1322-8
references.pmid: 19939578
references.citation: J Clin Oncol. 2005 Apr 20;23(12):2772-80
references.pmid: 15837992